title: [Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine].
authors: Daniel A
authors: DA
authors: García-Estévez
authors: Beatriz
authors: B
authors: San Millán
authors: Carmen
authors: C
authors: Navarro
authors: Teresa
authors: T
authors: Sogo
mesh_terms: D000659:AMP Deaminase / Q000172:deficiency* / Q000235:genetics; D000368:Aged; D019943:Amino Acid Substitution; D000069059:Atorvastatin; D001706:Biopsy; D015984:Causality; D052283:Creatine Kinase, MM Form / Q000097:blood; D017079:Exercise Tolerance; D005260:Female; D006538:Heptanoic Acids / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006720:Homozygote; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy; D027381:Liver-Specific Organic Anion Transporter 1; D008931:Mitochondria, Muscle / Q000502:physiology; D008957:Models, Genetic; D018482:Muscle, Skeletal / Q000473:pathology; D020125:Mutation, Missense; D063806:Myalgia / Q000209:etiology; D027361:Organic Anion Transporters / Q000235:genetics; D020734:Parkinsonian Disorders / Q000150:complications; D017354:Point Mutation; D020641:Polymorphism, Single Nucleotide; D011686:Purine-Pyrimidine Metabolism, Inborn Errors / Q000139:chemically induced / Q000235:genetics*; D011758:Pyrroles / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D014451:Ubiquinone / Q000172:deficiency
chemical_list: D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D027381:Liver-Specific Organic Anion Transporter 1; D027361:Organic Anion Transporters; D011758:Pyrroles; C503999:SLCO1B1 protein, human; D014451:Ubiquinone; D000069059:Atorvastatin; D052283:Creatine Kinase, MM Form; D000659:AMP Deaminase